世界の動脈瘤性クモ膜下出血市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Aneurysmal Subarachnoid Hemorrhage Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0326
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、動脈瘤性クモ膜下出血のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コンピューター断層撮影（CT）スキャン、磁気共鳴画像（MRI）、腰椎穿刺、キサントクロミー、脳血管造影、経頭蓋ドップラー超音波）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・動脈瘤性クモ膜下出血の市場動向
・企業の競争状況、市場シェア
・動脈瘤性クモ膜下出血の種類別市場規模（コンピューター断層撮影（CT）スキャン、磁気共鳴画像（MRI）、腰椎穿刺、キサントクロミー、脳血管造影、経頭蓋ドップラー超音波）
・動脈瘤性クモ膜下出血の用途別市場規模（病院、クリニック、その他）
・動脈瘤性クモ膜下出血の北米市場規模2016-2027（アメリカ、カナダ）
・動脈瘤性クモ膜下出血のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・動脈瘤性クモ膜下出血のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・動脈瘤性クモ膜下出血の中南米市場規模2016-2027（メキシコ、ブラジル）
・動脈瘤性クモ膜下出血の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Edge Therapeutics、Actelion Pharmaceuticals、Arbor Pharmaceuticals、Mayfield Brain & Spine、Europa Group、GE、Philips、Siemens、Trivitron、Toshiba）
・結論

Aneurysmal subarachnoid hemorrhage is a condition wherein a brain aneurysm ruptures, resulting in bleeding into the subarachnoid space.

Market Analysis and Insights: Global Aneurysmal Subarachnoid Hemorrhage Market
The global Aneurysmal Subarachnoid Hemorrhage market size is projected to reach US$ 175.3 million by 2026, from US$ 151.9 million in 2019, at a CAGR of 2.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Aneurysmal Subarachnoid Hemorrhage market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Aneurysmal Subarachnoid Hemorrhage market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Aneurysmal Subarachnoid Hemorrhage market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Aneurysmal Subarachnoid Hemorrhage market.

Global Aneurysmal Subarachnoid Hemorrhage Scope and Market Size
Aneurysmal Subarachnoid Hemorrhage market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Aneurysmal Subarachnoid Hemorrhage market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Lumbar Puncture
Xanthochromia
Cerebral Angiography
Transcranial Doppler Ultrasound

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Edge Therapeutics
Actelion Pharmaceuticals
Arbor Pharmaceuticals
Mayfield Brain & Spine
Europa Group
GE
Philips
Siemens
Trivitron

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Computed Tomography (CT) Scan
1.2.3 Magnetic Resonance Imaging (MRI)
1.2.4 Lumbar Puncture
1.2.5 Xanthochromia
1.2.6 Cerebral Angiography
1.2.7 Transcranial Doppler Ultrasound
1.3 Market by Application
1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Perspective (2016-2027)
2.2 Aneurysmal Subarachnoid Hemorrhage Growth Trends by Regions
2.2.1 Aneurysmal Subarachnoid Hemorrhage Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Aneurysmal Subarachnoid Hemorrhage Historic Market Share by Regions (2016-2021)
2.2.3 Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Regions (2022-2027)
2.3 Aneurysmal Subarachnoid Hemorrhage Industry Dynamic
2.3.1 Aneurysmal Subarachnoid Hemorrhage Market Trends
2.3.2 Aneurysmal Subarachnoid Hemorrhage Market Drivers
2.3.3 Aneurysmal Subarachnoid Hemorrhage Market Challenges
2.3.4 Aneurysmal Subarachnoid Hemorrhage Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Aneurysmal Subarachnoid Hemorrhage Players by Revenue
3.1.1 Global Top Aneurysmal Subarachnoid Hemorrhage Players by Revenue (2016-2021)
3.1.2 Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Players (2016-2021)
3.2 Global Aneurysmal Subarachnoid Hemorrhage Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Aneurysmal Subarachnoid Hemorrhage Revenue
3.4 Global Aneurysmal Subarachnoid Hemorrhage Market Concentration Ratio
3.4.1 Global Aneurysmal Subarachnoid Hemorrhage Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aneurysmal Subarachnoid Hemorrhage Revenue in 2020
3.5 Aneurysmal Subarachnoid Hemorrhage Key Players Head office and Area Served
3.6 Key Players Aneurysmal Subarachnoid Hemorrhage Product Solution and Service
3.7 Date of Enter into Aneurysmal Subarachnoid Hemorrhage Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Aneurysmal Subarachnoid Hemorrhage Breakdown Data by Type
4.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Type (2016-2021)
4.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Type (2022-2027)

5 Aneurysmal Subarachnoid Hemorrhage Breakdown Data by Application
5.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Application (2016-2021)
5.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size (2016-2027)
6.2 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type
6.2.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021)
6.2.2 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027)
6.2.3 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2027)
6.3 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application
6.3.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021)
6.3.2 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027)
6.3.3 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2027)
6.4 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country
6.4.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2016-2021)
6.4.2 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size (2016-2027)
7.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type
7.2.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021)
7.2.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027)
7.2.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2027)
7.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application
7.3.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021)
7.3.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027)
7.3.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2027)
7.4 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country
7.4.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2016-2021)
7.4.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size (2016-2027)
8.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Type
8.2.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2027)
8.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Application
8.3.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2027)
8.4 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region
8.4.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size (2016-2027)
9.2 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type
9.2.1 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021)
9.2.2 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027)
9.2.3 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2027)
9.3 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application
9.3.1 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021)
9.3.2 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027)
9.3.3 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2027)
9.4 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country
9.4.1 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2016-2021)
9.4.2 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size (2016-2027)
10.2 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Type
10.2.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2027)
10.3 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Application
10.3.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2027)
10.4 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country
10.4.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Edge Therapeutics
11.1.1 Edge Therapeutics Company Details
11.1.2 Edge Therapeutics Business Overview
11.1.3 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Introduction
11.1.4 Edge Therapeutics Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.1.5 Edge Therapeutics Recent Development
11.2 Actelion Pharmaceuticals
11.2.1 Actelion Pharmaceuticals Company Details
11.2.2 Actelion Pharmaceuticals Business Overview
11.2.3 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Introduction
11.2.4 Actelion Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.2.5 Actelion Pharmaceuticals Recent Development
11.3 Arbor Pharmaceuticals
11.3.1 Arbor Pharmaceuticals Company Details
11.3.2 Arbor Pharmaceuticals Business Overview
11.3.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Introduction
11.3.4 Arbor Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.3.5 Arbor Pharmaceuticals Recent Development
11.4 Mayfield Brain & Spine
11.4.1 Mayfield Brain & Spine Company Details
11.4.2 Mayfield Brain & Spine Business Overview
11.4.3 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Introduction
11.4.4 Mayfield Brain & Spine Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.4.5 Mayfield Brain & Spine Recent Development
11.5 Europa Group
11.5.1 Europa Group Company Details
11.5.2 Europa Group Business Overview
11.5.3 Europa Group Aneurysmal Subarachnoid Hemorrhage Introduction
11.5.4 Europa Group Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.5.5 Europa Group Recent Development
11.6 GE
11.6.1 GE Company Details
11.6.2 GE Business Overview
11.6.3 GE Aneurysmal Subarachnoid Hemorrhage Introduction
11.6.4 GE Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.6.5 GE Recent Development
11.7 Philips
11.7.1 Philips Company Details
11.7.2 Philips Business Overview
11.7.3 Philips Aneurysmal Subarachnoid Hemorrhage Introduction
11.7.4 Philips Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.7.5 Philips Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Siemens Business Overview
11.8.3 Siemens Aneurysmal Subarachnoid Hemorrhage Introduction
11.8.4 Siemens Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.8.5 Siemens Recent Development
11.9 Trivitron
11.9.1 Trivitron Company Details
11.9.2 Trivitron Business Overview
11.9.3 Trivitron Aneurysmal Subarachnoid Hemorrhage Introduction
11.9.4 Trivitron Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.9.5 Trivitron Recent Development
11.10 Toshiba
11.10.1 Toshiba Company Details
11.10.2 Toshiba Business Overview
11.10.3 Toshiba Aneurysmal Subarachnoid Hemorrhage Introduction
11.10.4 Toshiba Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
11.10.5 Toshiba Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Computed Tomography (CT) Scan
Table 3. Key Players of Magnetic Resonance Imaging (MRI)
Table 4. Key Players of Lumbar Puncture
Table 5. Key Players of Xanthochromia
Table 6. Key Players of Cerebral Angiography
Table 7. Key Players of Transcranial Doppler Ultrasound
Table 8. Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Regions (2016-2021)
Table 12. Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Regions (2022-2027)
Table 14. Aneurysmal Subarachnoid Hemorrhage Market Trends
Table 15. Aneurysmal Subarachnoid Hemorrhage Market Drivers
Table 16. Aneurysmal Subarachnoid Hemorrhage Market Challenges
Table 17. Aneurysmal Subarachnoid Hemorrhage Market Restraints
Table 18. Global Aneurysmal Subarachnoid Hemorrhage Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Players (2016-2021)
Table 20. Global Top Aneurysmal Subarachnoid Hemorrhage Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage as of 2020)
Table 21. Ranking of Global Top Aneurysmal Subarachnoid Hemorrhage Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Aneurysmal Subarachnoid Hemorrhage Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Aneurysmal Subarachnoid Hemorrhage Product Solution and Service
Table 25. Date of Enter into Aneurysmal Subarachnoid Hemorrhage Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type (2016-2021)
Table 29. Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Aneurysmal Subarachnoid Hemorrhage Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Application (2016-2021)
Table 33. Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2022-2027) & (US$ Million)
Table 65. Edge Therapeutics Company Details
Table 66. Edge Therapeutics Business Overview
Table 67. Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Product
Table 68. Edge Therapeutics Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 69. Edge Therapeutics Recent Development
Table 70. Actelion Pharmaceuticals Company Details
Table 71. Actelion Pharmaceuticals Business Overview
Table 72. Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product
Table 73. Actelion Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 74. Actelion Pharmaceuticals Recent Development
Table 75. Arbor Pharmaceuticals Company Details
Table 76. Arbor Pharmaceuticals Business Overview
Table 77. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product
Table 78. Arbor Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 79. Arbor Pharmaceuticals Recent Development
Table 80. Mayfield Brain & Spine Company Details
Table 81. Mayfield Brain & Spine Business Overview
Table 82. Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Product
Table 83. Mayfield Brain & Spine Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 84. Mayfield Brain & Spine Recent Development
Table 85. Europa Group Company Details
Table 86. Europa Group Business Overview
Table 87. Europa Group Aneurysmal Subarachnoid Hemorrhage Product
Table 88. Europa Group Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 89. Europa Group Recent Development
Table 90. GE Company Details
Table 91. GE Business Overview
Table 92. GE Aneurysmal Subarachnoid Hemorrhage Product
Table 93. GE Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 94. GE Recent Development
Table 95. Philips Company Details
Table 96. Philips Business Overview
Table 97. Philips Aneurysmal Subarachnoid Hemorrhage Product
Table 98. Philips Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 99. Philips Recent Development
Table 100. Siemens Company Details
Table 101. Siemens Business Overview
Table 102. Siemens Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 103. Siemens Recent Development
Table 104. Trivitron Company Details
Table 105. Trivitron Business Overview
Table 106. Trivitron Aneurysmal Subarachnoid Hemorrhage Product
Table 107. Trivitron Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 108. Trivitron Recent Development
Table 109. Toshiba Company Details
Table 110. Toshiba Business Overview
Table 111. Toshiba Aneurysmal Subarachnoid Hemorrhage Product
Table 112. Toshiba Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021) & (US$ Million)
Table 113. Toshiba Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Type: 2020 VS 2027
Figure 2. Computed Tomography (CT) Scan Features
Figure 3. Magnetic Resonance Imaging (MRI) Features
Figure 4. Lumbar Puncture Features
Figure 5. Xanthochromia Features
Figure 6. Cerebral Angiography Features
Figure 7. Transcranial Doppler Ultrasound Features
Figure 8. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Aneurysmal Subarachnoid Hemorrhage Report Years Considered
Figure 13. Global Aneurysmal Subarachnoid Hemorrhage Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Aneurysmal Subarachnoid Hemorrhage Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Regions: 2020 VS 2027
Figure 16. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Regions (2022-2027)
Figure 17. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Players in 2020
Figure 18. Global Top Aneurysmal Subarachnoid Hemorrhage Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Aneurysmal Subarachnoid Hemorrhage Revenue in 2020
Figure 20. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type (2016-2021)
Figure 21. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type (2022-2027)
Figure 22. North America Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2016-2027)
Figure 24. North America Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2016-2027)
Figure 25. North America Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2016-2027)
Figure 26. United States Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2016-2027)
Figure 30. Europe Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2016-2027)
Figure 31. Europe Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2016-2027)
Figure 32. Germany Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Share by Region (2016-2027)
Figure 42. China Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2016-2027)
Figure 50. Latin America Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2016-2027)
Figure 51. Latin America Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2016-2027)
Figure 52. Mexico Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2016-2027)
Figure 58. Turkey Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Edge Therapeutics Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 62. Actelion Pharmaceuticals Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 63. Arbor Pharmaceuticals Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 64. Mayfield Brain & Spine Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 65. Europa Group Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 66. GE Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 67. Philips Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 68. Siemens Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 69. Trivitron Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 70. Toshiba Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の頭蓋内出血診断・治療市場規模・現状・予測（2021年-2027年）

Global Intracranial Hemorrhage Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3223 2021年4月 90Pages
QYResearch社発行の本調査資料では、頭蓋内出血診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（装置、治療薬、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国...

世界の頭蓋内圧（ICP）モニタリング市場規模・現状・予測（2021年-2027年）

Global Intracranial Pressure(ICP) Monitoring Market Size, Status and Forecast 2021-2027
QYR2104Z3225 2021年4月 93Pages
QYResearch社発行の本調査資料では、頭蓋内圧（ICP）モニタリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（侵襲性頭蓋内圧モニター、非侵襲性頭蓋内圧モニター）、用途別市場規模（外傷性脳損傷、脳内出血、髄膜炎、くも膜下出血、その他（...

世界のディノプロストン市場規模・現状・予測（2021年-2027年）

Global Dinoprostone Market Size, Status and Forecast 2021-2027
QYR2104Z1900 2021年4月 91Pages
QYResearch社発行の本調査資料では、ディノプロストンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、膣坐剤、ジェル、錠剤、その他）、用途別市場規模（オキシトシン、分娩誘発、分娩後出血、その他）、主要地域別市場規模（北米、アメリカ、...

世界のパントプラゾール市場規模・現状・予測（2021年-2027年）

Global Pantoprazole Market Size, Status and Forecast 2021-2027
QYR2104Z4421 2021年4月 154Pages
QYResearch社発行の本調査資料では、パントプラゾールのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、錠剤、カプセル）、用途別市場規模（逆流性食道炎、ガストリノーマ、抗菌剤、胃腸出血、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のクロファラビン市場規模・現状・予測（2021年-2027年）

Global Clofarabine Market Size, Status and Forecast 2021-2027
QYR2104Z1384 2021年4月 99Pages
QYResearch社発行の本調査資料では、クロファラビンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エボルトラ、クロファラビン）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のスウェーデンポルフィリン症治療薬市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5519 2021年4月 95Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のエキソストシン1/2ヘテロダイマー市場規模・現状・予測（2021年-2027年）

Global Exostosin 1/2 Heterodimer Market Size, Status and Forecast 2021-2027
QYR2104Z2272 2021年4月 92Pages
QYResearch社発行の本調査資料では、エキソストシン1/2ヘテロダイマーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模...

世界のエキソストシン1/2ヘテロダイマー市場規模・現状・予測（2021年-2027年）

世界の脳血管造影市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cerebral Angiography Market The global Cerebral Angiography market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
世界の脳血管造影市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cerebral Angiography Market The global Cerebral Angiography market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
世界の頭蓋内出血診断・治療市場規模・現状・予測（2021年-2027年） Bleeding or haemorrhages loss of blood from the circulatory system which may be internal or external due to variety of conditions such as trauma, tissue damage due to surgery, accidents, cuts etc. Generally loss of 10–15% of the total blood volume does not cause serious mental problems and can be to…
世界の磁気共鳴画像（MRI）市場規模・現状・予測（2021年-2027年） We can use magnetic resonance imaging (MRI) to provide 2- or 3-D images of the brain for the study of its anatomy, function, or molecular processes... or a combination of all three. The nice thing about MRI is that a researcher can chose whether the focus should be anatomical with a little bit of fu…
世界の単一光子放射断層撮影（SPECT）市場規模・現状・予測（2021年-2027年） Preclinical SPECT imaging uses gamma rays to image rodent models of disease and is often combined with CT scans and PET imaging to generate quantifiable data on therapeutic compound binding and brain function. Market Analysis and Insights: Global Preclinical Single Photon Emission Computed Tomograph…